These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2930998)

  • 21. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.
    Edwards JG; Goldie A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):239S-248S. PubMed ID: 6337611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-over trial comparing the antidepressant effects of amineptine and maprotiline.
    Bornstein S
    Curr Med Res Opin; 1979; 6(2):107-10. PubMed ID: 380910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effect of maprotiline and chlorimipramine: controlled study.
    Montejo-Iglesias ML; Ramos-Brieva JA
    Neuropsychobiology; 1988; 19(1):20-4. PubMed ID: 3054622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
    Merideth CH; Feighner JP
    Acta Psychiatr Scand Suppl; 1983; 308():70-9. PubMed ID: 6230897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability.
    Clin Ther; 1983; 5(4):377-84. PubMed ID: 6347381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EEG assessment of the sedative and excitatory properties of CNS-active compounds in the patients with depression.
    Matousek M
    Neuropsychobiology; 1987; 17(1-2):118-20. PubMed ID: 2957608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrence of unipolar depression and efficacy of maprotiline].
    Rouillon F; Phillips R; Serrurier D; Ansart E; Gérard MJ
    Encephale; 1989; 15(6):527-34. PubMed ID: 2693074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant drugs in anergic schizophrenia. A double-blind cross-over study with maprotiline and placebo.
    Waehrens J; Gerlach J
    Acta Psychiatr Scand; 1980 May; 61(5):438-44. PubMed ID: 6105762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Further clinical experiences with maprotiline in endogeneous depressions].
    Náhunek K; Svestka J; Rysánek R; Cesková E
    Act Nerv Super (Praha); 1982 May; 24(2):81-7. PubMed ID: 7048835
    [No Abstract]   [Full Text] [Related]  

  • 33. Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
    Singh AN; Saxena B; Gent M; Nelson HL
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):451-62. PubMed ID: 816603
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U; Wendt G
    Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract]   [Full Text] [Related]  

  • 36. Maprotiline (Ludiomil)--another antidepressant.
    Med Lett Drugs Ther; 1981 Jun; 23(13):58-9. PubMed ID: 7017367
    [No Abstract]   [Full Text] [Related]  

  • 37. Recognizing and treating depressed patients with maprotiline.
    Lerfald SC
    Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Depressive states, occurrence and treatment in family practice. Randomized study of the efficacy of maprotiline (Ludiomil) and flupenthixol (Fluanxol)].
    Sederberg-Olsen P; Lauritsen B; Husfeldt P; Rønne H; Ekstrøm K; Bjørndal F; Holst B; Jakobsen K
    Ugeskr Laeger; 1981 May; 143(22):1383-7. PubMed ID: 7027568
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficacy of zimeldine in preventing depressive episodes in recurrent major depressive disorders--a double-blind placebo-controlled study.
    Björk K
    Acta Psychiatr Scand Suppl; 1983; 308():182-9. PubMed ID: 6230892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter evaluation of maprotiline hydrochloride for treatment of depression.
    Clin Ther; 1984; 6(2):155-62. PubMed ID: 6367987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.